(Q40161462)
Statements
Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin (English)
Wieslawa H Dragowska
Maïté Verreault
Donald T T Yapp
Corinna Warburton
Lincoln Edwards
Euan C Ramsay
Lynsey A Huxham
Andrew I Minchinton
Karen Gelmon
9 March 2007